The suture anchor allows secure fixation of soft tissue to bone and has become an invaluable tool for the orthopaedic surgeon. The original suture anchor was developed over 3 decades ago when a suture was bonded to a headless screw. Since then anchors have undergone a wide variety of design modifications to increase strength and allow for new applications based on biomechanical and clinical evidence. The suture anchor chain consists of the anchor to bone fixation, anchor suture interface, suture itself and suture to soft tissue interface. The early suture anchors failed most commonly from anchor pull out or breakage, with the strongest early design being a bone-screw-suture complex. Early concerns of metalwork complications saw the introduction of biodegradable suture anchors, originally lactic acid polymers and then osteoconductive bio-composites. Improvements in anchor design saw the suture become the main link of failure until the advent of novel suture materials made of ultrahigh molecular weight polyethylene. A form failure of suture at the anchor eyelet via cut-out led to redesign of the anchor suture interface with novel eyelet designs. Further innovations in the anchor suture interface have seen the advent of knotless anchors, especially useful in arthroscopic surgery. The newest products are all-suture anchors which show impressive strength whilst reducing the iatrogenic damage caused by insertion. The further biomechanical development of suture anchors is likely to produce new designs that continue to increase strength whilst managing size requirements for tailored clinical applications.
Introduction
The invention of the suture anchor has revolutionised orthopaedic surgery, allowing the rapid and efficient fixation of soft tissue to bone in both open and arthroscopic surgery. The evolution in anchor design to meet new demands and overcome demonstrated biomechanical shortfalls is a good example of evidence driven innovation. Anchors have found predominant application around the shoulder but are also commonly used in the hand, wrist and joints in the lower limb.
Whilst the applications of suture anchors are numerous and the surgical repairs can be quite complex, the sole function of a suture anchor is simple; to form a strong and stable point of bony fixation. Multiple advances in anchor design have occurred in the aim of maximising this function with variations in both form and material properties to optimise performance. Modern operative demands have seen the development of contemporary anchors with smaller design for use in more peripheral locations, and the use of biodegradable materials to combat perceived issues with persisting metal anchors, as well as the ability to use advanced anchors in arthroscopic procedures.
In view of the varying design features, the assessment of anchor efficacy remains simple, with suitability categorised into three overarching principals 1) maximise pull out strength, 2) minimise acute iatrogenic damage, and 3) minimise long term pro-arthritic potential.
The pull out force is the primary measure of an anchors performance. It is commonly measured by inline tensional loading often performed by a materials testing machine (Instron, Norwood, USA) and gives a value for the maximum load the anchor can withstand before it fails and is extracted from the bone (US Food and Drug Administration, 2017). The inline testing gives a pull out force representative of the worst-case scenario, with any angle less than 90°to the bone reducing the resultant contribution force to extraction. The minimisation of iatrogenic damage is a secondary performance criterion; however, size is the primary way to select one anchor over the other for a specific surgical purpose.
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The purpose of this narrative review is to report the history of anchor design, the performance of both legacy and contemporary implants and consider their suitability for different applications. Further, comments are made on the lessons learnt from previous design changes, in view of creating a firm foundation to allow better surgical selection of anchors and ongoing design innovation.
The original suture anchors
The first five suture anchors designed demonstrated varying mechanisms for bone fixation. A few early faults were rapidly corrected but many of the evident themes were carried through to future products. The first suture anchor was patented by Goble and Somers in 1985 and marketed as Statak (formerly Zimmer, Warsaw, USA). They described the bonding of a No.2 braided polyester to a self-drilling and tapping headless hex screw, allowing for the versatility of suture and the strength and ease of a threaded screw (Goble et al., 1994) . The Statak was designed for use in Bankart labral repair in the shoulder, it was made from titanium and had a pull out strength of 90 N (Carpenter et al., 1993) . The next anchor design was released by Mitek (formerly Mitek Inc., Canton, USA) and has undergone several iterations over the years all based on the same key concept. These anchors rely on the memory properties of a nitinol (nickel-titanium allow) arc, which straightens to allow insertion into a predrilled hole and then returns to the original curved shape in the cancellous bone catching on the edge of the cortex (Richmond et al., 1991) . The first generation Mitek anchor consisted of a single arc protruding from the end of a titanium body, but was rapidly superseded by Mitek G2 (Mitek Inc.) which consists of two arcs emerging from the side. The G2 design is analogous to that of a barbed arrow head which will allow insertion one way and then resist removal. The Mitek anchor range was first designed for use in the shoulder, however the range has undergone several modifications (Supplementary Table 1 ) -the sizes of anchor have varied in length and width with a range 1.3-to-2.9 mm. Mitek have facilitated an increase in pull out strength with each design iteration with ranges of 60 N to 460 N. The last of this group of "first generation" anchor designs was the Acufex TAG rod and wedge (Acufex Microsurgical Inc., Norwood, USA) which were polyactal (plastic) devices which generate traction in bone using an interference press fit, whereby their natural diameter is greater than that of the predrilled hole which they are pushed into (Barber et al., 1993) . The Acufex rod and wedge were designed for use in the shoulder, requiring a pre-drilled pilot hole of 3.7 and 3.1 mm. Despite being made from polyactal, the Acufex anchors had a pull out strength of 67 and 65 N respectively on initial testing. These anchor designs stood the test of time to become some of the most popular anchor choices for decades, with many subsequent designs modelled on the same principles (Table 1) .
Whilst Goble and Somers may have been the first inventors of a suture anchor, the first published evidence of the bone anchors' use in humans was in 1991 for the use of a Mitek G1 anchor by Richmond et al., despite no prior published evidence of biomechanical suitability (Richmond et al., 1991) . In this prospective single arm study, 32 patients underwent a modified Bankart reconstruction, with 17 of the patients followed up for 12 months or greater. The patients were reviewed for complications and assessed using the Bankart rating scale. There were no complications and the Bankart rating scale of 94% (good to excellent) compared to the high standard set by Rowe et al. when they found that traditional Bankart repair performed with suture tunnels resulted in an average of 97% on the Bankart rating scale (Rowe et al., 1978) . Although not a randomised controlled trial, these early results were promising, and all surgeons involved reported that the procedure was simplified. The same authors reported on the cohort at an average of 3 years follow up with only 2 failures over that timeframe, with what they describe as suboptimal placement in the glenoid rim (Levine et al., 1994) . The gold standard at the time for recurrent anterior glenohumeral instability was to undertake a repair with curved transosseous tunnels. This had proven reliability but was a more technically complicated and time consuming procedure. To simplify the technique, surgeons had attempted to use screws with washers or staples but irritation caused by metalware often necessitated removal and the size of the Bankart lesion precluded use in certain situations (Carpenter et al., 1993) . The other early application of suture anchors was in rotator cuff repairs.
In the early 1990s several biomechanical tests of the available suture anchors were published. The first study comparing all 5 of the available suture anchors at the time in cadaveric humeral specimens found failure at similar loads ranging from 70 to 120 N with a significant effect from bone quality and direction of pull, with lower force in the perpendicular direction (Carpenter et al., 1993) . The Mitek G1 was found to pull out of bone most often and with the lowest force and the G2 failed the least, this explains the subsequent preference for the G2 and relegation of the former. There was trouble with insertion of the original Acufex TAG rod, with almost one quarter breaking on insertion in hard bone with device fracture at the recess for the insertion device. The TAG Rod II removed this feature and there were no such difficulties reported with the revised implant . Failure of the suture anchor construct was described as failure of the suture anchor chain, whereby the chain was made up of the interlinked series of the tendon to suture, suture, suture to eyelet and the anchor to bone. The linking chain was described as having the potential for failure at any point in the series, however it was suggested that for satisfactory performance of the implant the anchor to bone should not be the weakest link in the chain (Barber et al., 1993) . These early results were significant as the average pull out loads were greater than the strength of commonly used No.2 Ethibond (~90 N) and so failure was largely by suture breakage (Gerber et al., 1994) . As the tendon-suture interface Table 1 Summary of first five anchor features and performance (Carpenter et al., 1993 L.E. Visscher et al. Clinical Biomechanics 61 (2019) 70-78 had in the past been recognised as weaker than the suture itself, this showed that anchor to bone would not be the weakest link in the chain. Goble et al. showed as per FDA marketing approval requirements that their original anchor design was equivalent to both transosseous tunnels or staples in reattaching the tibial collateral ligament in a sheep model (Goble et al., 1994) . Hecker et al. showed that in simulated models of Bankart lesions and rotator cuff repairs that suture anchors were not significantly different to sutures alone (Hecker et al., 1993) . Subsequent testing with the Statak anchor and newer designs such as the Mitek superanchor (containing 4 arcs; Mitek Inc.) demonstrated that suture anchors could be stronger than transosseous tunnels in rotator cuff repair (Craft et al., 1996; Reed et al., 1996) . The adoption of suture anchors was encouraged by the increasing popularity of arthroscopic surgery, and the recognition of likely reduced complications and post-operative discomfort when compared to open procedures (Koss et al., 1997) . In 1991 Wolf et al. described a technique for arthroscopic Bankart repair using Mitek suture anchors, negating the disadvantages of surgical complexity and increased operating time found in the suture only arthroscopic Bankart (Wolf, 1993) .
Anchor bone interface

Material choice
Early fears of metal anchors migrating over time, interfering with diagnostic imaging and consideration of suitability for the paediatric age group lead to the development of biodegradable suture anchors (Barber and Deck, 1995) . Published evidence of these feared complications did not emerge for another decade suggesting that the incidence rate was very low, but nevertheless degradable anchors provided peace of mind and were therefore attractive to the surgeon (Kaar et al., 2001; Silver and Daigneault, 2000) . Initially, biodegradable suture anchors were composed of either polyglycolic acid (PGA), stereoisomers of polylactic acid (PDLA/PLLA) or copolymers (PLGA) of these two materials. However, case reports emerged of inflammatory reactions and sterile cyst formation from rapidly degrading implants (Bostman, 1992; Edwards et al., 1994) . Different racemic mixtures have different degradation times due to the ability of the body to metabolise different stereoisomers (Table 2 ). This meant later degradable suture anchors were mostly composed of PLLA, with a longer degradation time of greater than 2 years (Barber, 2015) .
The performance of these biodegradable anchors has been under investigated, with most studies evaluating performance of the earlier implants. Regardless, biodegradable anchors have consistently shown lower pull out strength than metal anchors with ranges of 58 N to 522 N (Supplemental Table 2 ), and different failure mechanisms with biodegradable anchors more likely to fail by eyelet breakage (Barber et al., 2003) . Despite the known structural weakness when compared to metal equivalents, the use of biodegradable anchors was still clinically suitable as their pull out performance still met the failure requirements of chain mechanics. Even with the observed material weakness, the anchors still possessed significantly higher force than suture breakage points at the time and hence were still deemed suitable for use.
In 2000 Demierhan et al. assessed the clinical performance of the early biodegradable anchors with the Acufex PGA wedge (Acufex Microsurgical Inc.) compared to plastic version in an in vivo sheep model, demonstrating a significant drop in fixation strength of 84% with a decrease in pull out strength from 134 N to 23 N at 6 weeks (Demirhan et al., 2000) . This was worrying as the time frame for rehabilitation intensification lies around this time point, however the current applicability of this evidence is questioned as this research was performed with one of the faster degrading polymers no longer in clinical use. Meyer et al. tested biodegradable anchors in a low powered biomechanical study with 8 tests for each of the 12 different absorbable anchors available at the time -investigating displacement from polyurethane synthetic bone in a water bath at body temperature (37°C). Load to failure was tested with a materials testing (Instron) machine at 60 mm/min and static load testing was measured using constant load of 100 N and recording time to failure. Load to failure ranged from 124 to 244 N and under static loading two thirds of anchor models failed by eyelet cut-out in less than 100 h. This demonstrated that degradable anchors may fail within physiological force limits (Meyer et al., 2003a) . Despite these limited studies, the clinical use of biodegradable anchors has appeared acceptable, with detailed analysis of reported clinical outcomes showing no statistical difference between biodegradable and metallic anchors over time (Papalia et al., 2014) .
Ideally, biodegradable anchors would be replaced by bone, but clinical studies have shown that these biodegradable polyester blends are often replaced by calcified fibrous tissue (Barber and Dockery, 2006) . This has led to the adoption of bio-composite materials that may encourage osteoconductive ingrowth. The incorporation of calcium phosphates including β-tricalcium phosphate (β-TCP) and hydroxyapatite (HA) which are minerals found in natural bone, may lead to replacement by bone as the material degrades. Depuy-Mitek has patented a proprietary combination of 30% osteoconductive β-TCP and 70% PLGA marketed as Biocryl Rapide (DePuy Synthes, Raynham, USA). Other companies too have included HA and β-TCP in their anchor ranges. Daculsi et al. used press fit implants in an animal model to represent a soft tissue fixation device, with pure PDLA and biocomposites of PDLA/10% β-TCP and PDLA/24% β-TCP (Fig. 1) . The pure PDLA only showed evidence of hydrolysis surrounding the implant on light microscopy (6 months), whilst the biocomposites demonstrated bony bridging to the implant and trabecular formation at the β-TCP particles demonstrating osteoconductive properties (Daculsi et al., 2011) . A series of long term imaging studies in human subjects using interference screws of varying material compositions has demonstrated decreased degradation times but increased rates of bony ingrowth with the incorporation of calcium phosphates (Table 2 ; Barber et al., 2011a; Barber and Dockery, 2006, 2008; Dhawan et al., 2012) .
Size and shape
In 1995 F. Alan Barber published the first in a series of articles that would establish him as the authority on suture anchors . He used a fresh never frozen porcine femur model to test 10 samples of each of the 14 available anchors for pull out strength in cortical and cancellous bone. He would go on to use the same method to test a range of new to market anchors every few years for almost two decades. The results of these and other studies shaped the development of suture anchors over time. This initial experiment demonstrated Table 2 Degradation rates and osteoconductivity of polymers used in degradable Tissue Anchors (Barber et al., 2011a; Barber and Dockery, 2006, 2008; Dhawan et al., 2012) .
Material
Degradation time (months) Osteoconductivity (% bone evident on imaging) Complete bone ingrowth (%) Visscher et al. Clinical Biomechanics 61 (2019) 70-78 significantly higher pull out strength for screw type anchors Statak over non-screw anchors, and metal anchors over biodegradable anchors (Supplemental Table 3 ). These results meant that the most popular anchor designs have resulted from variations on the Statak screw type design, with variations in pitch, thread and eyelet design (Fig. 2) . However, whilst early Statak results may have shaped future anchor designs, a failure by the company to innovate to meet growing demands saw these anchors lose favour and become relegated by novel products. Understanding the mechanical performance of various designs became more important with the increased adoption of anchor use and extrapolation of established surgical techniques into other parts of the body. Although initial anchors were designed for the shoulder, specifically for Bankart and rotator cuff repairs, the efficiency of suture anchors was quickly recognised and reports were published of different applications in the wrist, hand and foot (Pederson et al., 1991; Rehak et al., 1994) . Potential issues with the rapid off label adoption of anchors designed for other parts of the body were recognised, and some early adopters were criticized for use of the large first generation anchors in small bones. Bones such as the lunate with delicate blood supply, were of specific concern and as such there was a need for site specific anchor designs, and this subsequently expanded the anchor range (Rehak et al., 1994) .
Initially from 1994, small bone anchors were focused on replicating the success that had been observed in the shoulder. These anchors looked to minimise the defect created in bone in order to reduce iatrogenic damage whilst maintaining a suitable pull out strength for the performance of the chain construct (A. . This range of anchors has been termed the "mini anchors" and is defined as anchors that result in a bone defect with an internal diameter of less than 2.2 mm (Barber et al., 1996) . Released in 1995 the MiniMitek (Mitek Inc.) was described for wide range of uses including Bankart repair, midfoot/hallux reconstruction, scapholunate reconstruction and thumb collateral ligament reconstruction (Rupp et al., 2002) . It had a size of 5.4 mm in length and 1.8 mm in width requiring a pre-drilled pilot hole of the same diameter. The Mitek GII design was retained with titanium body and two nitinol arcs, and the Mini Anchor and had a pull out strength of 67 N. Whilst the Statak 1.5 mm/2.5 mm had similar diameters, their length precluded them from use in many areas, and design flaws were reported to result in frequent breakage .
In 1996 Mitek released an even smaller anchor specifically for use in delicate hand surgery; it was first marketed for use in collateral ligaments around the PIP joint. This was termed the MicroMitek (Mitek Inc.) at size of 3.7 mm in length and 1.3 mm in width with a pull out strength of 49 N. The size of a micro anchor has not been defined in the literature but Depuy-Mitek (part of DePuy family from 2003) seems to have significant market share with another popular anchor of similar L.E. Visscher et al. Clinical Biomechanics 61 (2019) 70-78 dimensions to Tacit 2.0 (DePuy Synthes; Supplementary Table 4) . Also released in 1996 this titanium screw anchor has length 3.5 mm and 2 mm width requiring a pre drilled pilot hole of 1.2 mm with a pull out strength of 120 N (Barber et al., 1996) . As the size of the anchor decreased it was observed, as expected, that there was a decrease in the pull out force correlating to the reduction in the size of the drill diameter and the residual bony buttress (Barber and Herbert, 1999) . However, if the suture is sized appropriately so that the anchor-bone interface is stronger than the suture which is in turn stronger than the soft tissue, then the suture chain mechanics are maintained and the construct is acceptable (Barber et al., 1997b) .
Later anchor designs became more specialised for use in cancellous bone. The Corkscrew (Arthrex, Naples, USA) 3.5 mm suture anchor for example is a self-drilling screw anchor with 12 mm length, a small internal diameter tapering 1-1.7 mm and a wide thread depth creating an external diameter of 3.5 mm; the wider internal diameter at the base causes compression of the surrounding bone radially as it is inserted. This produces an impressive pull out strength of 556 N (and 672 N for its larger 5 mm counterpart), and the anchor is licenced for use in Bicep and Achilles tendon reattachment.
Bone cement has traditionally been used to augment the fixation of orthopaedic screws, especially in poor quality osteoporotic bone. Specialised cannulated screws have been developed that allow for ease of application (McKoy and An, 2000) . The same approach has been applied to suture anchors, a study this year demonstrated Healicoild Peek (Smith & Nephew) fenestrated anchors with injected cement had more than double the poll out strength in a rotator cuff repair model (Aziz et al., 2018) .
Chain failure at the suture
As rate of failure of the anchor construct decreased and mean force to pull out of bone increased, the failure point consistently became at the suture itself. In response companies began to provide anchors loaded with multiple sutures, two then three strands (Barber et al., 2003) . However, strength was still limited with no.2 braided polyester sutures failing at around 90 N. The introduction of ultrahigh molecular weight polyethylene (UHMWP) sutures (branded as Dyeema Purity, DSM, Heerlen, Netherlands) such as Fiberwire (Arthrex, Naples, USA) increased the strength of the linking chain significantly (Barber et al., 2003; De Carli et al., 2005) . These new sutures had around double the failure strength with 180 N for Fiberwire and there was rapid uptake and incorporation of the various new brands of suture into anchors (A. . This innovation in suture leads to the need to realise anchors with higher degrees of bony fixation. The strongest available anchors were mostly larger metal screw anchors, with large thread depths allowing for stronger hold especially on cancellous bone (Supplementary Table 5 ) so most new designs were variations on these ideas. Examples include the AME 5.5 (1995; AME International, Vienna, Austria) 800 N, the Questus 5.0 792 N (1995; Wright Medical Group, Memphis, Tennessee, USA), Twinfix 5.5 696 N (2006; Smith & Nephew, London, UK) and Corskcrew 5 672 N (Barber et al., 1996 (Barber et al., , 1997b Barber and Herbert, 2013) . Due to their size, the indications for these anchors are limited mostly to surgery about the shoulder, elbow, knee and ankle. A number of the strongest anchors released in recent years are biodegradable including the Biozip (2003; Stryker Corporation, Kalamazoo, USA) and SwiveLock C (2003; Arthrex), likely demonstrating an increased quality of these polymers with modern production (F.A. . Increased length of molecular weight polymer chains are known to increase strength (Warme et al., 1999) . The Biozip is the strongest anchor recorded at 817 N pull out strength, made of slowly degrading PLLA, it is 5 mm wide and recommended for insertion into a pilot hole made with an awl and is mostly used around the shoulder. A possible design feature contributing to the strength of the Biozip is the double healix thread. Another degradable anchor with an innovative feature is the CrossFT (2010; ConMed Corporation, Utica, USA) which is threaded with a widening pitch moving toward the tip of the anchor which would have the effect similar to a lag screw compressing the bone about the anchor vertically, producing a pull out strength of 688 N (Barber and Herbert, 2013) .
A notable exception to screw design is the Morphix released in 2013 (Medshape Inc., Atlanta, USA), requiring bone punch of 4.75 mm, it is a reiteration of an old design with a central plug pulled into the body causing splaying of the sides. The difference between this anchor and previous weaker examples is the large diameter of up to 15 mm once deployed, leading to a large pull out strength of 605 N (Barber and Herbert, 2013) . This size however limits its use to large joints.
A further material development to address the lesser mechanical performance of the biodegradable anchors was found in the introduction of the non-degradable plastic polyetheretherketone (PEEK). PEEK was shown to provide strong fixation in the range of 168 N to 605 N however, like the biodegradable anchors, does not interfere with imaging and allows for easy revision as it can be drilled through . These properties place it as an appealing midpoint between metal and degradable anchors and it has become a commonly utilised material choice. The first PEEK anchor released was the Bioraptor 2.3 (Smith & Nephew), a push in anchor which is a distant cousin of the TAG rod (Acufex acquired by Smith & Nephew 1995), with more ridges than the original to resist pull out up to 170 N (Barber and Dockery, 2008) . Another development in this anchor range was the Versalok (Depuy Synthes). Marketed for large joints, this consisted of a PEEK sleeve which would fit into a predrilled 4.9 mm pilot hole with a titanium pin being forced into the sleeve expanding the structure to 6.3 mm giving a pull out strength of 376 N .
The anchor-suture interface
The majority of testing for suture anchors utilised a similar method to Barber, testing for the direct pull out strength in an axial direction which was thought to be the weakest direction. In 1997 Burkhart recognised that for rotator cuff repairs cyclical loading might be more accurate method of simulating physiological loading conditions whereas all previous experiments had tested single pull to failure (Barber et al., 1997a) . In two separate experiments but utilising the same experimental setup he tested the effect of cyclical loading on simulated cadaveric rotator cuff repairs first with transosseous tunnels and then with Mitek Rotator Cuff anchors Burkhart et al., 1997b) . In evidence that strongly supported the use of suture anchors, he found them much less likely to fail compared to transosseous repairs. Importantly, the transosseous tunnels were found to fail with cyclical loading (simulating physiological loading) by suture cutting through bone a different mechanism when compared to suture breakage with single pull testing (Burkhart et al., 1997b) .
A new era of cyclical biomechanical testing began. The early mechanical performance of anchors was questioned and it was found that often anchors had a decreased ultimate failure load when assessed with a cyclical methodology, initially proposed to occur possibly due to crack propagation in the bone (Roth et al., 1998; Rupp et al., 2002) . A pivotal experiment by Rupp et al. showed that under cyclic conditions not just a reduction in ultimate tensile load but also a switch in the mechanism of failure from the suture itself to the suture at the sutureeyelet interface, which occurred due to wear of the suture on the sharp edges of the anchor (Rupp et al., 2002) . A finding further supported by Meyer when he observed that higher friction eyelets correlated with reduced breaking strength (Meyer et al., 2002) . Meyer demonstrated that direction of the suture affected failure strength, with breaking strength of some sutures reduced by up to 73% compared to the control of a polished steel hook when the direction of suture was at an axis not in line with the plane of insertion. The mechanism for this out of plane early failure phenomenon was attributed to eyelet design. At the time, numerous anchors were designed with 'protecting channels' aligned with the plan of insertion, this feature meant that when the suture is not axially aligned the resulting sharp edges of the eyelet come into contact with the suture and resulted in accelerated wear and early failure (Meyer et al., 2002) (Fig. 3) . This observation resulted in the authors advocating for smoother anchor eyelets such as those exhibited by the biodegradable anchors. Biodegradable anchors were found to be less prone to suture wear at the eyelet, but had their own issues with eyelet breakage due to weakened material performance attributing the eyelet in these anchors as one of the weakest links in the chain under cyclical loading conditions (Barber et al., 2003; Rupp et al., 2002) .
In 1995 Burkhart theorised on the optimal angle of the suture axis termed the "Deadman Theory". He stipulated based on Newtonian physics that the suture angle to the anchor should be less than 45°to reduce inline contribution forces and increase the overall pull out strength. However, results with original eyelet designs demonstrated suture wear at these "ideal" angles, increasing failure rate of the construct. Based on these findings a redesign of the eyelet was prompted to allow different suture exit angles, a feature quickly adopted by manufacturers and resulted in several innovative new suture attachment designs.
These changes often resulted in the attachment of the suture to the anchor through larger smoother eyelets, a central lumen, attaching to the central core or a distal portion. An example of the development of eyelet designs can be seen in the Linvatec Revo anchors (Conmed Corp., Utica, USA). The first Revo anchor (1994) was designed for use in Rotator Cuff repair and had a suture channel with sharp edges and pull out strength of 454 N . This eyelet was redesigned in the later SuperRevo (2001; Conmed Corp.) anchor which had a larger smooth eyelet to accommodate two sutures and allow sliding with low friction and pullout force of 469 N (Barber et al., 2003) . The Threevo (2005; Conmed Corp.) was later released holding three sutures (F.A. . Another novel eyelet design for metal anchors was seen in the Corkscrew FT (2004; Arthrex) anchor which had an internal crossbar for low friction suture attachment. This anchor was 16 mm in length and 5.5 mm diameter requiring a drill hole of 3.7 mm. Whilst the failure point of these anchors was often at the crossbar, this was at high loads in the range of 278-386 N . This eyelet bar breakage was even proposed to be a design feature and considered to be a safety mechanism to prevent anchor pull out into the joint (Barber et al., 2011b) . In biodegradable and plastic anchors new eyelets were designed to give greater strength. One approach was to make the eyelet transverse through the central body of the anchor as seen in the Bioraptor (2003; Smith & Nephew), a 2.9 mm push in anchor, designed to be inserted into a pilot hole of the same diameter with resistance of 374 N to pull out (F.A. . The later Healix (2011, Depuy Synthes) moved the 'eyelet' even further to the distal end of the anchor with pull out of 218 N . Another development in anchor eyelet design was the Bio-corkscrew (2003; Arthrex), which had an eyelet consisting of a loop of suture bonded into the PDLLA material, this anchor requires a pilot whole of 1.9-3.7 mm, is 5 mm wide with length of 15 mm and a pull out strength of 222 N (Barber et al., 2003) .
Novel anchor redesign
Knotless anchors
Whilst arthroscopic repairs were acknowledged as improving patient outcomes, the complexity and steep learning curve for consistent results in arthroscopic knot tying was recognised as a significant obstacle (Barber et al., 1997b) . In 2001 Thal published an article describing the first knotless suture anchor, called the Mitek Knotless (Mitek Inc.) . Similar to the Mitek GII design with a titanium body and nitinol arcs 11 mm in length and 2.8 mm in width, it had the additional feature of a distal groove. This allowed for a loop of suture to be attached through tissue, then engaged in the distal groove, with the anchor inserted in a predrilled hole allowing for knotless attachment. The Mitek knotless in initial testing had a statistically similar pullout force of 271 N vs 249 N for the Mitek GII in the same experiment, although this experiment was conducted by the patent holder so could be subject to bias (Thal, 2001) .
Initially two types of knotless anchors were described with different clinical applications (Leedle and Miller, 2005; Zumstein et al., 2004) . The first being the 'suture first' design in which the suture is initially passed through the tissue and then engaged in the distal groove and inserted into a predrilled hole and where the tension of the suture and the construct is determined by the depth of the anchor insertion (Fig. 4A ). An example of this was the Mitek knotless and similar later designs include the BioKnotless range (Depuy Synthes), available in PLLA and Biocryl Rapide which used this suture first method with biodegradable bodies relying on ridges for hold rather than the nitinol arc giving pull out strengths of 249 N and 265 N respectively . The Opus Magnum (2001; Smith & Nephew) and Ultrafix MiniMite (2002; Conmed Corp.) were released to allow for suture first knotless attachment. They are similar designs composed of stainless steel with mechanism deployment resulting in a horizontal bar (Magnum) or barbs (MiniMite) extending into predrilled hole and resisting pull out. The magnum has a resisting force of 509 N and the MiniMite 409 N (Barber et al., 2003; Barber and Herbert, 1999) .
The other form of knotless design is known as the 'through-tissue' configuration. In this design the anchor is passed through soft-tissue into the bone and by doing so, pulls with it a solid disk which holds the tendon (Robbe and Paletta, 2004) . These were simply additional components added to past suture anchors. The titanium Corkscrew 5 mm became the Corkscrew Parachute Tissue Anchor (Arthrex), with the resistance of 672 N provided by the anchor. The TwinfixTi5.0 anchor (Smith & Nephew) was known as the Quick-T Fixation System with 448 N of pull out force.
With the acceptance of knotless designs, further innovation was invested in these implants by manufacturers in order to gain market dominance. The main feature was that of tensionable suture anchors. The first suture-first knotless anchors required varying insertion depth to achieve the desired tension which is imprecise. Anchors were developed to allow the tensioning of suture prior to deployment. The first examples were Kinsa anchors (2006; Smith & Nephew) a push in anchor range 3.4 mm wide designed for a 2.9 mm pilot hole, containing a Fig. 3 . Eyelet design with 'suture protecting channels' which provided sharp angles when not axially aligned (Meyer et al., 2002) .
'midshipmans knot' a self-locking sliding knot allowing for tension, and with a pull out strength of 219 N . The Swivelock C (2006; Arthrex) has a distal eyelet separate from the body which allows suture tensioning before insertion forces the two pieces together holding the suture, this anchor has a pull out force of 712 N. The Versalok mentioned previously holds the suture once the titanium pin mechanism is deployed. The Bioraptor Knotless (2006, Smith & Nephew) has an innovative design with a push in anchor with ridges with an internal locking screw within its body that secures the suture. Another design innovation is evident within the Cinch Piton Knotless Fixation Implant (2009; Wright Medical, Memphis, USA). With two metal eyelets creating a ratcheting effect, this nitinol anchor has barbs which work similar to Mitek arcs and has a pull out strength of 379 N (Barber et al., 2011b) . The Quattro Link (2013; Zimmer Biomet, Warsaw, USA) has an eyelet toward the tip which contains a cleat that maintains the tension of suture, before anchor insertion holds it compressed against the bone giving a pullout strength of 482 N (Barber and Herbert, 2013) .
These new designs were useful in facilitating the double-row rotator cuff technique which was gaining popularity after having been proposed by Lo & Burkhart in 2003 (Lo and Burkhart, 2003) . Whilst knotless anchors were originally developed for the glenoid to avoid tedious knot tying, they became more widely applied as lateral row anchors. The ability to tension anchors was ideal to fix sutures passed from the medial row to form the suture-bridge . Anchors were specifically developed for use in the lateral row including the Footprint (2010; Smith & Nephew) and Opus Speedscrew (2008; Smith & Nephew) . The Footprint is a tap in anchor 5.5 mm in diameter with offset barbs that prevent removal from its 3.9 mm pilot hole giving a pull out force of 454 N (Barber and Herbert, 2013) . It has a distal eyelet allowing tensioning before insertion locks the suture against bone. The Opus Speedscrew 6.5 mm wide by 16 mm length can hold several sutures and has an internal locking mechanism that holds sutures within the hollow body of the anchor after tensioning, it has a pull out force of 357 N (Barber et al., 2011b) . These designs all promoted a functional advantage whilst still maintaining mechanical performance (Supplementary Table 8 ) and hence resulted in mass adoption, most notably in the shoulder.
Innovative surgeons have applied tensionable suture anchors for ligament attachment elsewhere in the body to overcome the difficulties of maintaining tension whilst tying sequential knots. Bain (senior author) and colleagues have described the repair of collateral ligaments in the unstable elbow using tensionable anchors (Lee et al., 2012) . They have also documented scapholunate repair using a modified Brunelli technique, and report that if the suture from one tensionable anchor is passed into another then 'anchors in series' can be created for both a ligament fixation and diastasis reduction (Bain et al., 2013) .
All suture anchors
Recently, additional focus has been placed on the pro arthritic potential of anchor use. As such designers have looked to introduce to the market implants that are a) smaller in size, so not to extensively disrupt the articulating surface b) soft in form, so to not unnecessarily damage the surrounding tissue, and c) knotless in design to avoid pressure forming foci.
As a result from this attempt to minimise this anchor induced arthritic change the 'suture-only' or 'all-soft' suture anchors were developed. Initially described for use in labral repair, these anchors were designed to attach to a smaller diameter bone defect compared to solid anchors, theoretically preserving bone strength and reducing the risk of damage with anchor pull out (Mazzocca et al., 2012) . Examples of all suture anchors include the Iconix (Stryker), Y-Knot (Conmed Inc.), Juggerknot (Zimmer Biomet), Q-Fix (Arthrocare, Austin, USA) and Draw Tight (Parcus Medical, Sarasota, USA). Functioning by deploying the anchor inside a predrilled hole by placing the larger suture slip or suture ball under tension resulting in radial expansion creating an interference fit, as seen with the Q-Fix (Fig. 4B) . Biomechanical testing results are sparse but initial results suggest that these anchors have similar or better strength when compared to solid anchors with the mechanical performance (Barber and Herbert, 2017) .
Conclusion
Both the design and use of suture anchors has changed dramatically since their inception in 1985. With increased expectations from a device that originally had only the role of resisting pull out, anchors now must match the structural performance of their predecessors whilst being smaller in size, made of safer radiolucent materials, being selftensioning and knotless.
Through a process of evidence driven innovation, extensive changes have occurred in the form of bony fixation, eyelet placement, axis of suture exit, materials and functional mechanics. These modifications have resulted in safer, stronger and more functional implants and have facilitated the expansion of use to applications in the shoulder as well as the small bones and joints of the extremities. There is strong evidence around strength and suitability of different suture anchors, but there remains more work to be done in the biomechanics of anchor fixation. The majority of evidence has come from a single author, this has the benefit of ensuring consistent testing technique but warrants validation from other groups.
Despite previous progress there are still areas for improvement in performance, and with ever increasing operative demands and surgical expectations there will always be a need for further development. This article looks to provide a foundation on the important factors of anchor design as well as detailed narrative of past innovations. It is the hope that by understanding and appreciating the lessons in this paper that Fig. 4 . Novel Anchor designs. A) Knotless anchor designs, left to right three 'suture first' designs Bioknotless RC (Mitek Inc., Canton, USA), Knotless Suture Anchor (Mitek Inc.), UltraFix Knotless MiniMite (Conmed Corp., Utica, USA) and three 'through-tissue' Corkscrew Parachute (Arthrex, Naples, USA), Magnum Knotless (Conmed Corp., Utica, USA), and TwinFix Ti (Smith & Nephew, London, UK). B) All suture anchor Q-Fix 2.8 before and after deployment, demonstrating the increase in diameter that secures the anchor in a predrilled hole. Modified with permission (Barber and Herbert, 2017; Robbe and Paletta, 2004) . the reader will be better equipped to select appropriate anchors for clinical use as well as propose and critically review future solutions in this area of continual development.
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